The move came after Dr. Chin complied with scheduled payments required over a five-year contingency period, the release said. The charges stemmed from consulting fees. All surgeon payments were disclosed annually to CMS, which dispelled money laundering allegations.
Dr. Chin didn’t comment on the dismissal in the news release. He is the former CEO of SpineFrontier.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
